SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

CAPR is trending as investors await Phase 3 trial data, with community discussions focused on potential outcomes and the company's future. Optimism is fueled by analyst ratings and prior trial results, while concerns linger around the timing of data release and potential price manipulation by shorts. The stock's volatility reflects the high stakes riding on the upcoming data.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending, with community chatter focused on the potential for a short squeeze and the actions of Ryan Cohen. Discussions revolve around the high number of synthetic shares and the belief that short positions are trapped, while some investors express impatience for a clear strategy regarding the company's cash reserves. The stock is being viewed by some as undervalued based on its cash position and profitability.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is gaining attention amidst discussions about its potential acquisition of Northern Data and its implications for expanding GPU and AI capabilities. Community members are actively analyzing the impact of Tether's involvement, including potential ad spending and cloud GPU rentals, on Rumble's future earnings. High short interest is fueling speculation about a potential short squeeze, with some seeing the stock as undervalued given its growth and strategic partnerships.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor ($OPEN) is trending as investors discuss Goldman Sachs taking a 5% stake, viewing it as a strong bullish signal and potential catalyst for a significant price increase. The community is also focused on upcoming tradable warrants, anticipating a short squeeze and further upward momentum. Talk centers around the company's potential for growth in the real estate market and a possible turnaround.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

AQST is trending as investors discuss the potential impact of a competitor's earnings report and institutional ownership updates. Community members are weighing the significance of SPRY's results on AQST's future, while also considering the upcoming PDUFA date and the possibility of a partnership or acquisition. Bullish sentiment remains due to the company's technology and potential, though some express concerns about market penetration and the overall market's influence.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors discuss the upcoming CHMP opinion on Blarcamesine, its Alzheimer's drug, with community members weighing approval prospects and potential market impact. Despite recent price drops, some believe a positive opinion could trigger a significant short squeeze, while others highlight the potential for a precision medicine approach. Discussions also include potential partnerships and buyout scenarios following the regulatory decision.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

Galecto (GLTO) is trending due to significant price volatility and speculation around a potential short squeeze, with chatter focused on its low float and high cost to borrow. Community members are debating whether to chase the momentum, take profits, or anticipate a further run-up, while others warn of a potential pump and dump. The stock's association with other high-flying tickers and its relevance to the cancer treatment sector are also contributing to the heightened interest.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

LKNCY is trending as investors eagerly await news of a potential U.S. relisting and the upcoming earnings report, with community sentiment reflecting anticipation for positive catalysts. The community is buzzing with speculation around the timing of the report and its potential impact, viewing it as a critical juncture for the company's growth narrative. Some investors believe a relisting announcement could be imminent, while others express concerns about a possible delay.

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Aaron Leabman in January 2018 and is headquartered in Pleasanton, CA.

Movano Inc

Movano is trending due to news of a merger, sparking high volatility and trading volume. The community is actively discussing potential short squeezes and price targets, while also weighing the implications of the merger on the company's valuation and share structure. Traders are closely watching the stock's price action and potential for further upward movement given its low float.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending as traders discuss the implications of Michael Burry's short position against the stock, with many suggesting a potential squeeze is underway. Community members are debating the company's valuation and growth prospects, particularly in the context of its AI capabilities and government contracts. The stock's recent volatility and potential for further upward momentum are also key talking points.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Canaccord Genuity has adjusted their stance on Wallbox ( $WBX ), setting the rating to Buy with a target price of 15 → 9.